| 2024 |
Brewer, K., Wignall, A., Bazeed, A., Gundsambuu, B., Kohlhagen, J., Yan, J., . . . Blencowe, A. (2024). Customizable and Open-Source 3D Printed Inserts for Controlled Release and Cell Culture Experiments. ACS Applied Polymer Materials, 6(19), 11813-11827. DOI |
| 2022 |
Bazeed, A. Y., Day, C. M., & Garg, S. (2022). Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies. Cancers, 14(17), 36 pages. DOI Scopus48 WoS42 Europe PMC39 |
| 2022 |
Nasr, M., Saber, S., Bazeed, A. Y., Ramadan, H. A., Ebada, A., Ciorba, A. L., . . . Elagamy, H. I. (2022). Advantages of cubosomal formulation for gatifloxacin delivery in the treatment of bacterial keratitis: in vitro and in vivo approach using clinical isolate of methicillin-resistant staphylococcus aureus. Materials, 15(9, article no. 3374), 1-10. DOI |
| 2021 |
Nasr, M., Almawash, S., Al Saqr, A., Bazeed, A. Y., Saber, S., & Elagamy, H. I. (2021). Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles. Pharmaceuticals, 14(8, article no. 786), 1-11. DOI |
| 2021 |
Bazeed, A. Y., Nouh, A., Essa, E. A., & El Maghraby, G. M. (2021). Hydrophilic sugars for enhancing dissolution rate of cilostazol: effect of wet co-processing. Pharmaceutical Sciences, 27(1), 111-120. DOI |
| 2020 |
Bazeed, A. Y., Essa, E. A., Nouh, A., & El Maghraby, G. M. (2020). Co-processing of nateglinide with meglumine for enhanced dissolution rate: in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy, 46(10), 1676-1683. DOI |